Innate immune cells – and many other cells – express evolutionarily conserved, germline-encoded receptors that recognize seemingly pathogen-derived ligands (also termed pathogen-associated molecular patterns), thereby allowing the host to perceive infection. Although they were the first to be discovered, Toll-like receptors (TLRs) are not the only pattern recognition receptors. TLRs are unlikely to discriminate between commensals and pathogens in the gut microbiota. There is, however, increasing evidence that TLRs shape intestinal function. In addition, certain bacteria appear to drive either Th1/Th17 proinflammatory immune responses, or T regulatory responses. Furthermore, TLRs appear to trigger ‘sterile’ autoinflammatory responses by sensing metabolically altered host (self) components.

Keywords:
Toll-like receptor, Intestinal diseases
1.
Metchnikoff E: Lectures on the Comparative Pathology of Inflammation (reprinted from London, Keegan, Paul, Trench, Trübner, 1893. New York, Dover, 1968).
2.
von Behring EA, Kitasato S: Über das Zustandekommen der Diphterie Immunität und der Tetanus Immunität bei Tieren E. Dtsch Med Wochenschr 1890;16:1113.
3.
Janeway CA Jr: Presidential Address to The American Association of Immunologists. The road less traveled by: the role of innate immunity in the adaptive immune response. J Immunol 1998;161:539–544.
4.
Skidmore BJ, Morrison DC, Chiller JM, Weigle WO: Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med 1975;142:1488–1508.
5.
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996;86:973–983.
6.
Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394–397.
7.
Beutler B, Cerami A: The biology of cachectin/TNF – a primary mediator of the host response. Annu Rev Immunol 1989;7:625–655.
8.
Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085–2088.
9.
Kawai T, Akira S: Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011;34:637–650.
10.
Gross O, Thomas CJ, Guarda G, Tschopp J: The inflammasome: an integrated view. Immunol Rev 2011;243:136–151.
11.
Suzuki M, Hisamatsu T, Podolsky DK: Gamma interferon augments the intracellular pathway for LPS recognition in human intestinal epithelial cells through coordinated upregulation of LPS uptake and expression of the intracellular TLR4-MD-2 complex. Infect Immun 2003;71:3503–3511.
12.
Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, Lee HK, Shen C, Cojocaru G, Shenouda S, Kagnoff M, Eckmann L, Ben-Neriah Y, Raz E: Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006;8:1327–1336.
13.
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59–65.
14.
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, et al: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:20–21.
15.
Lathrop SK, Bloom SM, Rao SM, et al: Peripheral education of the immune system by colonic commensal microbiota. Nature 2011;478:250–254.
16.
Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK: The TLR2 pathway establishes colonisation by a commensal of the human microbiota. Science 2011;332:974–977.
17.
Matzinger P: Tolerance, danger, and the extended family. Ann Rev Immunol 1994;12:991–1045.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.